Coronary stent thrombosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Stent thrombosis}}
{{Stent thrombosis}}
{{CMG}} ; '''Associate Editors-In-Chief:''' Smita Kohli, M.D.; [[ William J Gibson]]; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S.
{{CMG}} ; '''Associate Editors-In-Chief:''' Smita Kohli, M.D.; [[ William J. Gibson]]; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S.


==[[Stent thrombosis introduction|Introduction]]==
==[[Stent thrombosis introduction|Introduction]]==

Revision as of 12:24, 16 July 2011

Coronary stent thrombosis Microchapters

Home

Introduction

Definition

Epidemiology and Demographics

Relation to Bare Metal Stents
Relation to Drug Eluting Stents
Relation to Antiplatelet Medications

Pathophysiology

Risk Factors

Relationship to Discontinuation of Antiplatelet Therapy

Treatment

Complications

Prevention

Coronary stent thrombosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Coronary stent thrombosis

CDC onCoronary stent thrombosis

Coronary stent thrombosis in the news

Blogs on Coronary stent thrombosis

to Hospitals Treating Coronary stent thrombosis

Risk calculators and risk factors for Coronary stent thrombosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editors-In-Chief: Smita Kohli, M.D.; William J. Gibson; Varun Kumar, M.B.B.S.; Lakshmi Gopalakrishnan, M.B.B.S.

Introduction

Definition

Overview | Issues with interpreting data | Definition based on timing of ST | Definition based on certainty of ST

Incidence

Relation to Bare Metal Stents | Relation to Drug Eluting Stents | Sirolimus eluting stent vs Paclitaxel eluting stent | Relation to antiplatelet medications

Mechanism and Pathophysiology

Overview | Mechanisms and pathophysiology | Clinical trial data

Etiology

Predictors of stent thrombosis | Risk factors for early ST | Risk factors for late ST | Risk factors for very late ST

Premature discontinuation of antiplatelet therapy

Incidence | Predictors | Risk associated with premature discontinuation | Risk associated with late discontinuation | Duration of therapy | Failure of therapy | Prevention of premature discontinuation

Treatment

Prognosis

Recurrence of stent thrombosis | Myocardial infarction

Prevention

Overview | Clinical trial data | Guidelines


Template:WikiDoc Sources